Welcome to our investor pages
Medical technology company Optomed is leading producer of handheld fundus cameras globally.
- Net sales 13,0 EUR, million
- Gross margin 68.8 %
- Adjusted EBITDA -0.7 EUR, million
- Equity ratio 64.6 %
Share Price
Nasdaq Helsinki Stock Exchange
Latest releases
Next IR events
Jun 2
- Jun 2, 2021
Red Eye Growth Day
Aug 5
- Aug 5, 2021
Optomed will publish H1 2021 Financial Report
Sep 13
- Sep 13, 2021
Kepler Cheuvreux Autumn Conference 2021
Sep 28
- Sep 28, 2021
Redeye Medtech & Diagnostics
Nov 4
- Nov 4, 2021
Optomed will publish Q3-2021 Interim Report
Nov 11
- Nov 11, 2021
Redeye Life Science Day
Optomed as an investment
Optomed is a research and development as well as sales driven medical technology company in expansion phase.
Optomed is one of the leading players in the growing and transforming handheld fundus camera market.
Read more
